Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $29.63. The company's market cap stands at 167.74B, with a P/E ratio of 39.17 and a dividend yield of 5.81%.
During the trading session on 2026-10-20, Pfizer(PFE) shares reached a daily high of $29.69 and a low of $29.25. At a current price of $29.63, the stock is +1.3% higher than the low and still -0.2% under the high.
Trading activity shows a volume of 20.82M, compared to an average daily volume of 29M.
The stock's 52-week range extends from a low of $23.62 to a high of $29.88.
The stock's 52-week range extends from a low of $23.62 to a high of $29.88.
PFE News
Pfizer (PFE -0.47%) is a stock that the market has largely forgotten about for multiple years, languishing and struggling to rise in value despite having strong...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has completed its Phase 2 MAGNETISMM-3 study, formally titled “MAGNETIS...
Investing Pfizer’s Dividend Freeze Raises a Bigger Question About Its Cash Flow Pfizer's 5.8% yield looks tempting until you check what the dividend is actually...
Analyst ratings
59%
of 29 ratingsMore PFE News
Investing These 5 Dividend Stocks Look Like Income Bargains. The Math Says Otherwise A yield above 6% looks like a retirement lifeline until the math behind it...
shares have climbed back into focus after a year of double digit gains, and the current quote raises a straightforward question about whether that price lines u...
Pfizer secured expanded FDA approval for TUKYSA in HER2 positive metastatic breast cancer and released extensive infectious disease data across vaccines and tre...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer has quietly reshaped parts of its pipeline th...
Last week, drugmaker Pfizer (PFE +0.36%) declared a $0.43 fourth-quarter dividend, its 352nd consecutive quarterly dividend. The forward annual dividend, theref...
Investing Bristol Myers Squibb’s 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know Bristol Myers Squibb has raised its dividend for 17 straight y...
Investing Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady Vaccine stocks are cracking under intense selling pressur...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.